Prestige Consumer Healthcare (NYSE:PBH) Stock Price Down 15.9% - Should You Sell?

Key Points

• Prestige Consumer Healthcare shares fell 15.9% in Thursday’s mid-day trading, dropping from a prior close of $53.28 to about $44.79.
• Analyst sentiment is mixed but averages to a Hold, with a consensus price target of $67.67; ratings include one Buy, three Holds, and one Sell.
• The company beat quarterly estimates, reporting EPS of $1.13 versus $1.07 expected and revenue of $336.31 million, up 22.7% year over year.

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) traded down 15.9% during mid-day trading on Thursday. The stock traded as low as $45.48 and last traded at $44.7850. 100,272 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 559,134 shares. The stock had previously closed at $53.28.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Weiss Ratings reiterated a "sell (d+)" rating on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 22nd. Zacks Research downgraded Prestige Consumer Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 29th. One equities research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of "Hold" and an average price target of $67.67.

Prestige Consumer Healthcare Price Performance

The company has a market cap of $2.11 billion, a price-to-earnings ratio of 12.43, a price-to-earnings-growth ratio of 1.55 and a beta of 0.30. The stock has a 50 day simple moving average of $48.49 and a two-hundred day simple moving average of $53.99. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.23 and a quick ratio of 1.99.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.06. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%. The company had revenue of $336.31 million during the quarter, compared to analyst estimates of $329.14 million. During the same period in the prior year, the business posted $1.07 earnings per share. The firm's revenue for the quarter was up 22.7% compared to the same quarter last year. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.56 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

A number of hedge funds have recently made changes to their positions in PBH. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $30,000. Versant Capital Management Inc increased its position in shares of Prestige Consumer Healthcare by 47.9% in the 2nd quarter. Versant Capital Management Inc now owns 726 shares of the company's stock valued at $34,000 after purchasing an additional 235 shares during the last quarter. Cornerstone Planning Group LLC acquired a new stake in shares of Prestige Consumer Healthcare in the 1st quarter valued at $44,000. Pinnacle Wealth Planning Services Inc. raised its holdings in shares of Prestige Consumer Healthcare by 69.3% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,153 shares of the company's stock valued at $53,000 after purchasing an additional 472 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Prestige Consumer Healthcare by 19.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 1,531 shares of the company's stock valued at $91,000 after purchasing an additional 249 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc NYSE: PBH is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions.

The company's brands include Dramamine and Bonine for motion-sickness relief; BC and Goody's for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer's Eve for feminine care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.